spacer
EDP Sciences Journals List
Home arrow Document
Subscriber Authentication Point
 
About the journal
Author information
Subscriber information
Reader's services
Related Books
Events
Advertising
  • English
  • French
  
 Previous article
Next article 
   Table of contents

|   Abstract  |   PDF (275.9 KB)  |   References  |

Free access article

References of Radioprotection 40 57-71
  1. Bonet-Maury P., Patti F. (1950) L'irradiation mortelle de la souris par les rayons X et $\gamma$. Essais thérapeutiques, J. Radiol. Electrol. Arch. Electr. Méd. 31, 286-290.
  2. Célariès B., Court L., Lion C., Rima G., Roman V. (2001a) Organometallic compounds of silicon and germanium in chemical radioprotection, Main Group Met. Chem. 25, 58.
  3. Célariès B., Rima G., Court L., Lion C., Roman V., Laval J.D. (2001b) Radioprotective activity and synthesis of siladithioacetals and germadithioacetals derived from N-substituted naphthylethylimidazoline, Metal-Based Drugs 8, 199-210.
  4. Célariès B., Amourette C., Lion C., Rima G. (2003a) Radioprotective activity of metalladithioacetals derived from N-substituted naphthylethylimidazoline, Appl. Organomet. Chem. 17, 135-138 [CrossRef].
  5. Célariès B., Amourette C., Lion C., Rima G. (2003b) Synthesis and radioprotective study of new siladithioacetals and germadithioacetals, Appl. Organomet. Chem. 17, 561-569 [CrossRef].
  6. Davidson D.E., Grenan M.M., Sweeney T.R. (1980) Radiation Sensitizers. Their use in the clinical management of cancer (Luther W. Brady, Ed.) p. 309. Masson pub., USA.
  7. Fatôme M., Sentenac-Roumanou H., Lion C., Satgé J., Fourtinon M., Rima G. (1984) Radioprotective effect of germanium dithioacetals of cysteamine and methylcysteamine, Eur. J. Med. Chem. 19, 119-122.
  8. Fatôme M., Sentenac-Roumanou H., Lion C., Satgé J., Rima G. (1988) Study of germathiazolidines and germylated dithioacetals derived from N-substituted cysteamine and methylcysteamine: synthesis and radioprotective activity, Eur. J. Med. Chem. 23, 257-266 [CrossRef].
  9. Finney D.J. (1971) Probit. Analysis: a statistical treatment of the sigmoid response curve, 3rd edn. Cambridge University Press.
  10. Laval J.D., Roman V., Laduranty J., Miginiac L., Lion C., Sentenac-Roumanou H., Fatôme M. (1993) Radioprotective effect of low doses of 2-(1-naphthylmethyl)-2-imidazoline alone or associated with phosphorothioates, Eur. J. Med. Chem. 28, 709-713 [CrossRef].
  11. Piper J.R., Stringfellow C.R., Elliot R.D., Johnston T.P. (1969a) S-2-(omega-aminoalkylamino)ethyl dihydrogen phosphorothioates and related compounds as potential antiradiation agents, J. Med. Chem. 12, 236-243.
  12. Piper J.R., Stringfellow C.R., Johnston T.P. (1969b) Terminally substituted S-2-(omega-aminoalkylamino)ethyl dihydrogen phosphorothioates and related compounds as potential antiradiation agents, J. Med. Chem. 12, 244-253.
  13. Porta C., Maiolo A., Tua A., Grignani G. (2000) Amifostine, a reactive oxygen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF, Haematologica. 85, 820-825.
  14. Rima G., Satgé J., Fatôme M., Laval J.D., Sentenac-Roumanou H., Lion C., Lazraq M. (1991) Syntheses and radioprotective activities of trithiagermatranes, trithiasilatranes, germylated oxide and sulfide with cysteamine and N-(2-thioethyl)-1,3-diaminopropane hydrochloride ligands, Eur. J. Med. Chem. 26, 291-297 [CrossRef].
  15. Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Lion C., Laval J.D. (1993) New organogermylated compounds N-substituted by naphthylmethylimidazoline hydrochloride, and imidazoline: synthesis and radioprotective activity, Eur. J. Med. Chem. 28, 761-767 [CrossRef].
  16. Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Laval J.D., Lion C., Alazard O., Chabertier P. (1994) Synthesis and radiopharmacological study of new metalated thiazolidines and dithioacetals of N-allyl-substituted cysteamine and methylcysteamine, Appl. Organomet. Chem. 8, 481-490 [CrossRef].
  17. Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Laval J.D., Lion C., Dagiral R. (1996) New germaheterocycles, germadithioacetals and a germylated oxide and sulfide derived from cysteamine, methylcysteamine and N-substituted cysteamine: synthesis and radioprotective activity, Appl. Organomet. Chem. 10, 113-123.
  18. Rima G., Satgé J., Sentenac-Roumanou H., Fatôme M., Laval J.D., Lion C., Thiriot C., Dagiral R., Martin C. (1997) Synthesis and radioprotective properties of new metallathiazolidines, dialkyloxathiagermolanes, dialkylgermocanes and metalladithioacetals, Main Group Met. Chem. 20, 255-267.
  19. Rima G., Satgé J., Dagiral R., Lion C., Fatôme M., Roman V., Laval J.D. (1998) Synthesis and radioprotective activity of new organosilicon and germanium compounds, Metal-Based Drugs 5, 139-146.
  20. Rima G., Satgé J., Dagiral R., Lion C., Fatôme M., Roman V., Laval J.D. (1999a) Synthesis and application of new organometallic compounds of silicon and germanium in chemical radioprotection, Appl. Organomet. Chem. 13, 583-594 [CrossRef].
  21. Rima G., Satgé J., Dagiral R., Lion C., Sentenac-Roumanou H., Fatôme M., Roman V., Laval J.D. (1999b) A review on the radioprotective activity of organogermanium and organosilicon compounds, Metal-Based Drugs 6, 49-60.
  22. Satgé J., Cazes A., Bouchaut M., Fatôme M., Sentenac-Roumanou H., Lion C. (1982) Synthesis and radioprotective activity of germa- and silathiazolidines, Eur. J. Med.Chem. 17, 433-436.
  23. Satgé J., Rima G., Fatôme M., Sentenac-Roumanou H., Lion C. (1989) Syntheses and radioprotective activities of germatranes, silatranes, germylated oxides and sulfides with cysteamine, methylcysteamine and N-(2-thioethyl)-1,3-diaminopropane hydrochloride ligands, Eur. J. Med. Chem. 24, 48-54 [CrossRef].
  24. Washburn L.C., Carlton J.E., Hayes R.L., Yuhas J.M. (1974) Distribution of WR 2721 in normal and malignant tissues of mice and rats bearing solid tumors. Dependence on tumor type, drug dose, and species, Radiat. Res. 59, 475-483.
  25. Washburn L.C., Rafter J.J., Hayes R.L., Yuhas J.M. (1976) Prediction of the effective radioprotective dose of WR-2721 in humans through an interspecies tissue distribution study, Radiat. Res. 66, 100-105.
  26. Yuhas J.M. (1970) Biological factors affecting the radioprotective efficiency of S-2-[2-aminopropylamino] ethylphosphorothioic acid (WR-2721). LD50/30j doses, Radiat. Res. 44, 621-628.
  27. Yuhas J.M. (1972) Improvement of lung tumor radiotherapy through differential chemoprotection of normal and tumor tissue, J. Natl-Cancer Inst. 48, 1255-1257.
  28. Yuhas J.M. (1973) Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), J. Natl-Cancer Inst. 50, 69-78.